✦ LIBER ✦

Incidence and Predictors of Hepatitis B E Antigen (HBeAg) Seroconversion in Chronic Hepatitis B (CHB) Patients Treated With Anti-HBV Therapy in Routine Clinical Practice

✍ Scribed by Lin, Brian ;Ha, Nghiem B. ;Liu, Anne ;Trinh, Huy N. ;Nguyen, Huy A. ;Nguyen, Khanh K. ;Garcia, Ruel T. ;Ahmed, Aijaz ;Garcia, Gabriel ;Keeffe, Emmet B. ;Nguyen, Mindie H.

Book ID: 122138271
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 570 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)63861-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence of Hepatitis B E Antigen (HBeA

Incidence of Hepatitis B E Antigen (HBeAg) Seroconversion and Suboptimal Response in Chronic Hepatitis B (CHB) Patients Treated With Entecavir 0.5 mg Daily in Routine Clinical Practice

✍ Liu, Anne ;Ha, Nghiem B. ;Lin, Brian ;Yip, Benjamin ;Trinh, Huy N. ;Nguyen, Huy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 806 KB

10 HBV-DNA markers predictive of respons

10 HBV-DNA markers predictive of response to lamivudine (LAM) therapy in patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B

✍ A. Ciancio; A. Smedile; M. Rizzetto; M. Lagget; A. Olivero; M.L. Abate; J. Gerin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Patterns of hepatitis B viral load level

Patterns of hepatitis B viral load level (HBV DNA), hepatitis B e antigen (HBeAg) status and risk factors of cirrhosis and hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients in Thailand

✍ S. Leuangarun; T. Sriprayoon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB

49 Association between HBeAg seroconvers

49 Association between HBeAg seroconversion and sustained HBV-DNA suppression in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) for HBeAg-positive chronic hepatitis B (CHB)

✍ T. Piratvisuth; G.K.K. Lau; P. Marcellin; W.C. Chow; G. Cooksley; M.W. Fried; S. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 131 KB

OL-026 Kinetics of interleukin-18 and HB

OL-026 Kinetics of interleukin-18 and HBV DNA during IFN-therapy induced and spontaneous anti-HBeAg seroconversion in patients with chronic hepatitis B

✍ Staffan Sylvan; Ulla Hellstrom 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Long-term outcomes of thymosin-α1 and in

Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B

✍ Murat Saruc; Nuri Ozden; Nurten Turkel; Semin Ayhan; Lynette M. Hock; Isil Tuzcu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

Hepatitis B e antibody (HbeAb) and hepatitis B virus (HBV) DNA positive chronic hepatitis is a clinical entity, distinct from classical hepatitis B e antigen (HbeAg) positive chronic hepatitis B. Our aim was to evaluate the long-term therapeutic efficacy of the combination of interferon alpha-2b and